骨髓状新生体的进展:超越骨髓母细胞
Carlos Faria1,2, Alexandar Tzankov2
1Department of Anatomical Pathology, Coimbra University Hospital, Coimbra, Portugal.
概括
骨髓瘤 (MN) 可以通过不太常见的途径发展到急性骨髓瘤之外,包括获得其他骨髓瘤疾病的特征或转化为骨髓瘤或淋巴细胞白血病. 了解这些不同的进展路线对于有效的患者管理至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤 (MN),包括骨髓质综合征 (MDS),骨髓质-骨髓增殖性瘤 (MDS/MPN) 和骨髓增殖性瘤 (MPN),是死亡的一个重要原因.
- 脑膜炎的进展通常以转变为急性髓性白血病或由瘤克隆过度生长的正常血液形成为特征.
研究的目的:
- 为了阐明在髓状瘤中疾病进展的不太公认但反复出现的途径.
- 突出不同基因突变在驱动这些多样化的MN转变类型中的作用.
- 强调认识到这些途径对于最佳患者管理的重要性.
主要方法:
- 对骨髓瘤瘤进展的临床和分子数据的审查和综合.
- 分析与特定转化场景相关的遗传突变.
- 组织病理学发现的相关性,包括外骨髓性疾病,与不同的进展类型.
主要成果:
- 确定了七种不太常见的MN进展场景:在MDS中获得MPN特征,在MPN中获得MDS特征,进展性髓纤维化,CMML类型的转变,髓状肉瘤,淋巴细胞转变以及囊细胞/树突细胞外生.
- 将特定突变 (例如,JAK2,ASXL1,IDH1/2,RAS基因,FLT3,NPM1,MAPK路径基因) 与不同的进展类型联系起来.
- 在这些不太常见的MN转换中观察到一种倾向于外参与的倾向.
结论:
- 骨髓瘤表现出多样化且不太常见的进展途径,超出了急性骨髓瘤白血病的转变.
- 特定的遗传变化与这些独特的进化轨迹有关,影响疾病行为和外骨髓传播.
- 对这些多样化的进展类型的认识对于准确的诊断和针对MN患者的量身定制的治疗策略至关重要.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
10.0K
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Disorders of Leukocytes
992
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
992
Production of Formed Elements
1.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.5K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
